Medicament for treating neonatal tetanus

Abstract

The invention relates to a medicament for treating neonatal tetanus. The medicament is prepared from the following Chinese herbal medicines as active ingredients in parts by weight: 5-12 parts of bombyx batryticatus, 2-5 parts of cinnabaris, 2-6 parts of realgar, 6-15 parts of semen crotonis pulveratum, 5-12 parts of scorpion, 8-15 parts of radix glycyrrhizae. The medicament achieves the effects of dispelling wind and coursing the exterior, detoxifying and relieving spasm, clearing away the heart fire and relieving convulsion, and is good in curative effect, free from toxic and side effects, and the total effective rate of the treatment can achieve up to 97.9%.

Description

technical field [0001] The invention relates to the field of biomedicine, in particular to a medicine for treating neonatal tetanus. Background technique [0002] Neonatal tetanus is one of the common diseases of newborns after unclean delivery. It is an acute infectious disease caused by the invasion of tetanus bacteria from the umbilicus and occasionally from the trauma of newborns. Neonatal tetanus is a developing serious health problems in the country. Most of the symptoms manifested by the children are that the children are conscious and have no fever in the early stage. Later, the rise in body temperature may be caused by repeated tonic spasms of the muscles of the whole body, or secondary infections such as pneumonia. Those who can pass the spasm period after timely treatment , its attack gradually reduces, relieves, and recovers after a few weeks, otherwise it will die due to more frequent, hypoxic suffocation or secondary infection. [0003] At present, in the tre...

AI Technical Summary

Problems solved by technology

[0003] At present, in the treatment of neonatal tetanus, in addition to the strict disinfection of the umbilical cord, the method of diazepam injection and luminal injection is often used alternately. The stable half-life is short, so the number of static injections should be more, and the amount is difficult to control. In addition, because the newborn is relatively weak, intramuscular injection will cause damage to the newborn's skin and increase the pain of the newborn.